San Francisco Luncheon with Heather Mac Donald (SOLD OUT)

March 7, 2018
500 California Street, San Francisco, CA, USA
150320221647327704

How Campus Victimology is Remaking the “Real World”

Featuring Q&A Session with PRI Senior Fellow Dr. Steven F. Hayward

The Pacific Research Institute invites you to a special noon luncheon with Heather Mac Donald, the Thomas W. Smith Fellow at the Manhattan Institute and a contributing editor to City Journal. Mac Donald will discuss the latest assaults on free speech both within the academy and outside of it. She will explain the causes of the growing censorship and suggest how to combat it.

Wednesday, March 7, 2018
Noon Luncheon

Omni San Francisco
500 California Street
San Francisco, CA 94104

Luncheon Ticket: $60
Sir Antony Fisher Freedom Society & YLC Members: $30

For more information, please contact Vickie Nelson, Director of Events, at
(415) 955-6110 or [email protected].

***SOLD OUT***

Registration is closed for this event.

Mac Donald, a recipient of the 2005 Bradley Prize, has written extensively on how race-based attacks on the criminal justice system by Black Lives Matter and other groups are undermining the authority of law and putting lives at risk. Her recent speeches at UCLA and Claremont McKenna College were disrupted by protesters.

Tell Your Friends

Related

pharmaceutical warehouse.

Trump Puts Drug Pricing Program Fraudsters on Notice

The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And that effort could help make care more affordable for ...
Californians Hit With Hundreds of Dollars in Annual Fees

California Governor Candidate Becerra’s Price Controls Would Backfire on Families

At a recent California gubernatorial debate, former Attorney General Xavier Becerra was asked which specific cost, gas, groceries, utilities, or childcare, would he lower first ...
pharmaceutical warehouse.

Germany Wants Cheaper Drugs—And Americans To Pay The Difference

What does a new healthcare reform effort in Germany have to do with American patients? Quite a lot, actually. The German government is looking to ...
Scroll to Top